{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:07:27Z","timestamp":1784761647365,"version":"3.55.0"},"reference-count":49,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2012,3,12]],"date-time":"2012-03-12T00:00:00Z","timestamp":1331510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2012,4]]},"abstract":"<jats:p><jats:bold>WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT<\/jats:bold><\/jats:p><jats:p>\u2022\u2003New onset diabetes after transplantation is related to treatment with immunosuppressive medications. Clinical studies have shown that risk of new onset diabetes is greater with tacrolimus compared with ciclosporin. The diabetogenicity of ciclosporin and tacrolimus has been attributed to both beta cell dysfunction and impaired insulin sensitivity.<\/jats:p><jats:p><jats:bold>WHAT THIS STUDY ADDS<\/jats:bold><\/jats:p><jats:p>\u2022\u2003This is the first trial to investigate beta cell function and insulin sensitivity using gold standard methodology in healthy human volunteers treated with clinically relevant doses of ciclosporin and tacrolimus. We document that both drugs acutely increase insulin sensitivity, while first phase and pulsatile insulin secretion remain unaffected. This study demonstrates that ciclosporin and tacrolimus have similar acute effects on glucose metabolism in healthy humans.<\/jats:p><jats:p><jats:bold>AIM<\/jats:bold> The introduction of calcineurin inhibitors (CNIs) ciclosporin (CsA) and tacrolimus (Tac) has improved the outcome of organ transplants, but complications such as new onset diabetes mellitus after transplantation (NODAT) cause impairment of survival rates. The relative contribution of each CNI to the pathogenesis and development of NODAT remains unclear. We sought to compare the impact of CsA and Tac on glucose metabolism in human subjects.<\/jats:p><jats:p><jats:bold>METHODS<\/jats:bold> Ten healthy men underwent 5\u2003h infusions of CsA, Tac and saline in a randomized, double\u2010blind, crossover study. During infusion glucose metabolism was investigated using following methods: a hyperinsulinaemic\u2010euglycemic clamp, an intravenous glucose tolerance test (i.v.GTT), glucose\u2010stimulated insulin concentration\u2013time series and indirect calorimetry.<\/jats:p><jats:p><jats:bold>RESULTS<\/jats:bold> Clamp derived insulin sensitivity was increased by 25% during CsA (P &lt; 0.0001) and 13% during Tac administration (P = 0.047), whereas first phase and pulsatile insulin secretion were unaffected. Coinciding with the CNI induced improved insulin sensitivity, glucose oxidation rates increased, while insulin clearance rates decreased, only non\u2010significantly. Tac singularly lowered hsCRP concentrations, otherwise no changes were observed in circulating glucagon, FFA or adiponectin concentrations. Mean blood concentrations of CNIs were 486.9 \u00b1 23.5\u2003\u00b5g\u2003l<jats:sup>\u22121<\/jats:sup> for CsA and 12.8 \u00b1 0.5\u2003\u00b5g\u2003l<jats:sup>\u22121<\/jats:sup> for Tac.<\/jats:p><jats:p><jats:bold>CONCLUSIONS<\/jats:bold> Acute effects of i.v. CsA, and to a lesser degree Tac infusions, in healthy volunteers include increased insulin sensitivity, without any effect on first phase or pulsatile insulin secretion.<\/jats:p>","DOI":"10.1111\/j.1365-2125.2011.04118.x","type":"journal-article","created":{"date-parts":[[2011,10,11]],"date-time":"2011-10-11T15:55:31Z","timestamp":1318348531000},"page":"536-545","source":"Crossref","is-referenced-by-count":42,"title":["Calcineurin inhibitors acutely improve insulin sensitivity without affecting insulin secretion in healthy human volunteers"],"prefix":"10.1111","volume":"73","author":[{"given":"Lara Aygen","family":"\u00d8zbay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Juhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"Bjerre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Carstens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen","family":"Rungby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj Anker","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,3,12]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00349.x"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-6143.2003.00010.x"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2007.01749.x"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1600-6143.2003.00372.x"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.3.583"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000069952.49242.3E"},{"key":"e_1_2_7_8_2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1681\/ASN.V131213","article-title":"Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine\u2010based immunosuppression","volume":"13","author":"van Duijnhoven EM","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm544"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067411"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199710150-00008"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000245844.27683.48"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199908150-00012"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.63.6.1289"},{"key":"e_1_2_7_15_2","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2337\/diab.35.9.1049","article-title":"Direct effects of cyclosporin A on human pancreatic beta\u2010cells","volume":"35","author":"Nielsen JH","year":"1986","journal-title":"Diabetes"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.01018.x"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199203000-00014"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V123583"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfl820"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.3109\/08037059709086440"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)91943-4"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(98)01633-9"},{"key":"e_1_2_7_23_2","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1681\/ASN.V124828","article-title":"Approaching the therapeutic window for cyclosporine in kidney transplantation: a prospective study","volume":"12","author":"Mahalati K","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(03)00481-0"},{"key":"e_1_2_7_25_2","first-page":"E478","article-title":"Pulsatile insulin secretion accounts for 70% of total insulin secretion during fasting","volume":"269","author":"Porksen N","year":"1995","journal-title":"Am J Physiol"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021181"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00516.2000"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(88)90110-2"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1983.55.2.628"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-005-1850-z"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.38.1.58"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200005270-00017"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2289"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V131221"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000145435.80005.1E"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199507000-00007"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199911270-00017"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(91)90293-K"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.2337\/db10-0299"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0445"},{"key":"e_1_2_7_41_2","first-page":"172","article-title":"Epinephrine acutely mediates skeletal muscle insulin resistance","volume":"94","author":"Bessey PQ","year":"1983","journal-title":"Surgery"},{"key":"e_1_2_7_42_2","first-page":"E86","article-title":"Effects of a growth hormone pulse on total and forearm substrate fluxes in humans","volume":"258","author":"Moller N","year":"1990","journal-title":"Am J Physiol"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2426"},{"key":"e_1_2_7_44_2","first-page":"161","article-title":"Effects of cyclosporine on circulating levels of prolactin, LH, FSH, TSH and GH in chronic hyperprolactinemic male rats","volume":"52","author":"Lafuente A","year":"1996","journal-title":"Rev Esp Fisiol"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32833c20eb"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1080\/07315724.2003.10719326"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2009.00849.x"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2007.06.023"},{"key":"e_1_2_7_49_2","first-page":"113","article-title":"Effect of cyclosporine on insulin binding to erythrocytes in type 1 diabetes mellitus of recent onset","volume":"11","author":"Behme MT","year":"1988","journal-title":"Clin Invest Med"},{"key":"e_1_2_7_50_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.3.624"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2125.2011.04118.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2125.2011.04118.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T21:28:47Z","timestamp":1697405327000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2125.2011.04118.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,12]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["10.1111\/j.1365-2125.2011.04118.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2125.2011.04118.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,12]]}}}